Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06853899 · ClinicalTrials.gov registry record · NA
Clinical Trial to Evaluate the Efficacy of Skin Products to Improve Skin Quality and Health
A NA study of Skin Aging and Skin Hydration, sponsored by Truology.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT06853899: Completed NA study of Skin Aging and Skin Hydration, sponsored by Truology.
NCT06853899 is a NA study of Skin Aging and Skin Hydration that has completed, run by Truology. The registered enrollment target is 33 participants, below the 72-participant average among 9 other Skin Aging trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06853899, a NA study of Skin Aging and Skin Hydration, has completed, sponsored by Truology.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial evaluates the efficacy of three skincare products-Truology A2 (0.2% Retinaldehyde Serum), Truology C-Boost, and Truology Barrier Restore-in improving skin quality and health. The study will assess improvements in skin firmness, evenness, brightness, hydration, fine lines/wrinkles, redness, and skin stress/irritation.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Truology A2
- DIETARY_SUPPLEMENT Truology C-Boost
- DIETARY_SUPPLEMENT Truology Barrier Restore
Study Locations (1)
Nevada
- Citruslabs - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2024-10-21 |
| Est. Completion | 2025-01-10 |
| Phase | NA |
What the finished NCT06853899 record still lists
NCT06853899 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 72-participant average among 9 other Skin Aging trials with a reported enrollment target (54% lower).
The record links to 2 conditions, with Skin Aging appearing as the primary indexed condition, and to 3 interventions - of which Truology A2 is the first listed.
NCT06853899 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT06853899 about?
NCT06853899 is a clinical study titled "Clinical Trial to Evaluate the Efficacy of Skin Products to Improve Skin Quality and Health". This clinical trial evaluates the efficacy of three skincare products-Truology A2 (0.2% Retinaldehyde Serum), Truology C-Boost, and Truology Barrier Restore-in improving skin quality and health. The study will assess improvements in skin firmness, evenness, brightness, hydration, fine lines/wrinkles...
What is the current status of trial NCT06853899?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2024-10-21. Estimated completion is 2025-01-10.
What conditions does trial NCT06853899 study?
This clinical trial studies the following conditions: Skin Aging, Skin Hydration.
What interventions are being tested in trial NCT06853899?
The interventions under investigation include: Truology A2 (DIETARY_SUPPLEMENT), Truology C-Boost (DIETARY_SUPPLEMENT), Truology Barrier Restore (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06853899?
This trial is sponsored by Truology, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06853899 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06853899's enrollment target sits among peer trials
33 7th of 9 higher than 3 of 9 other Skin Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Skin Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging
ACTIVE NOT RECRUITING · NA
-
A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging, by Comparing to a Placebo
ACTIVE NOT RECRUITING · NA
-
Thermage CPT for Treatment of Facial and Neck Laxity
COMPLETED · NA
-
Relationship of Skin Related SNP to Topical Skin Care Product
COMPLETED · NA
-
A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Skinpen on Male and Female Subjects' Dorsal Hands as a Treatment of Hand Aging
COMPLETED · NA
-
Efficacy of a Dietary Supplement on Parameters of Skin Aging in Men and Women
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI